Veeva Systems Q4 revenue eases past estimates

Veeva Systems

04/03/2026 21:22

Overview

Life sciences cloud provider's Q4 revenue grew 16%, beating analyst expectations

Adjusted net income for Q4 beat analyst expectations

Outlook

Veeva expects Q1 revenue between $855 mln and $858 mln

Company projects FY 2027 revenue between $3,585 mln and $3,600 mln

Veeva targets $6 bln revenue run rate by 2030

Result Drivers

AI INTEGRATION - Veeva's integration of industry-specific AI into its applications contributed to strong Q4 performance

R&D AND QUALITY SOLUTIONS - Growth in Veeva's Development Cloud and Quality Cloud, with several top 20 biopharma wins, boosted Q4 results

COMMERCIAL SOLUTIONS - Adoption of Vault CRM by major biopharma companies supported revenue growth, with 10 top 20 biopharmas committed globally

Company press release: ID:nPnbDbbGYa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$835.95 mln
$810.62 mln (25 Analysts)
Q4 EPS
$1.45
Q4 Adjusted Net Income
Beat
$346.10 mln
$327.88 mln (23 Analysts)
Q4 Net Income
$244.20 mln
Q4 Adjusted Operating Income
Beat
$366.50 mln
$351.08 mln (25 Analysts)
Q4 Pretax Profit
$317.54 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 24 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Veeva Systems Inc is $299.50, about 61.1% above its March 3 closing price of $185.91

The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 28 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)